News Chart PharmaEssentia Corporation

Equities

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
593 ^TWD	+1.54%		+7.04%	+71.39%

Jul. 05	Pharmaessentia Corporation Receives Approval of China National Medical Products Administration for Application of Ropeginterferon alfa-2b for PV	CI
Jul. 02	PharmaEssentia Corporation Announces Update on its IND Application of Phase I Clinical Trial of Sequential Treatment of P1801 Following P1101 in Patients with Advanced Solid Tumors	CI

3ed1.48F1cZ0YQc8OJy8DR9xsHN8rm-h9jvxZeARRBwVm550.j4o7FtFbcKE8YEJPCYg4UYhF1Jkn6I4tLUM1XkEfpPeoiE078y0Nlk1jZg~15ca0da30b7a3113bb01980795673c24